NASDAQ
EyePoint Pharmaceuticals, Inc. (EYPT) has a fcf yield of -18.19% as of Friday, May 29, 2026. This represents a 24.96% increase compared to its 12-month average of -24.23%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.